BAM Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$537K Buy
2,053
+704
+52% +$180K 0.29% 88
2026
Q2
$339K Buy
1,349
+362
+37% +$77.9K 0.21% 124
2026
Q1
$215K Buy
987
+53
+6% +$11.8K 0.16% 146
2025
Q4
$213K Buy
+934
New +$213K 0.15% 147

Other funds holding ABBV

BAM Wealth Management's ABBV Position: Q3 2026 in Review

BAM Wealth Management increased its AbbVie (ABBV) stake by 52% in Q3 2026, buying an estimated $180K and bringing the position to 2,053 shares worth $537K. The position accounts for 0.29% of the portfolio, ranked #88.

BAM Wealth Management first reported a position in ABBV in Q4 2025 and has held it in 4 quarters since. 4,281 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • BAM Wealth Management held 2,053 shares of AbbVie worth $537K as of Q3 2026.
  • BAM Wealth Management bought 704 AbbVie shares in Q3 2026, an estimated $180K.
  • AbbVie made up 0.29% of BAM Wealth Management's portfolio in Q3 2026, its #88 holding.
  • BAM Wealth Management first reported a position in AbbVie in Q4 2025 and has held it in 4 quarters since.
  • 4,281 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on BAM Wealth Management's 13F filing for Q3 2026, filed 15 Oct 2026.